|
Alivus Life Sciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
12821.36 Cr.
|
P/BV
|
4.05
|
Book Value (Rs.)
|
257.91
|
|
52 Week High/Low (Rs.)
|
1225/819
|
FV/ML
|
2/1
|
P/E(X)
|
22.71
|
|
Bookclosure
|
01/09/2025
|
EPS (Rs.)
|
45.99
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 45.99 | 39.63 | 38.43 | 38.11 | 35.63 |
| Diluted EPS (Rs.) | 45.90 | 39.53 | 38.38 | 38.11 | 35.63 |
| Cash EPS (Rs.) | 52.13 | 44.58 | 42.79 | 41.55 | 37.27 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 271.49 | 229.92 | 190.35 | 174.51 | 167.66 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 271.49 | 229.92 | 190.35 | 174.51 | 167.66 |
| Dividend / Share (Rs.) | 0.00 | 5.00 | 22.50 | 21.00 | 21.00 |
| Revenue From Operations / Share (Rs.) | 207.91 | 194.79 | 186.35 | 176.39 | 173.29 |
| PBDIT / Share (Rs.) | 69.88 | 58.53 | 56.01 | 54.78 | 51.48 |
| PBIT / Share (Rs.) | 63.74 | 53.58 | 51.65 | 51.35 | 48.39 |
| PBT / Share (Rs.) | 61.21 | 53.38 | 51.52 | 51.30 | 46.11 |
| Net Profit / Share (Rs.) | 45.99 | 39.63 | 38.43 | 38.11 | 34.17 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 33.61 | 30.04 | 30.05 | 31.05 | 29.70 |
| PBIT Margin (%) | 30.65 | 27.50 | 27.71 | 29.11 | 27.92 |
| PBT Margin (%) | 29.44 | 27.40 | 27.64 | 29.08 | 26.60 |
| Net Profit Margin (%) | 22.12 | 20.34 | 20.62 | 21.60 | 19.72 |
| Return on Networth / Equity (%) | 16.94 | 17.23 | 20.18 | 21.83 | 20.38 |
| Return on Capital Employeed (%) | 22.51 | 22.32 | 26.24 | 28.62 | 28.40 |
| Return On Assets (%) | 14.17 | 14.23 | 16.51 | 17.28 | 16.94 |
| Asset Turnover Ratio (%) | 0.69 | 0.76 | 0.82 | 0.83 | 0.95 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 5.21 | 4.97 | 4.37 | 3.67 | 4.60 |
| Quick Ratio (X) | 3.85 | 3.53 | 2.85 | 2.47 | 3.25 |
| Inventory Turnover Ratio (X) | 3.74 | 3.56 | 3.59 | 1.96 | 1.95 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 58.54 | 82.65 | 30.72 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 52.57 | 75.81 | 28.17 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 41.46 | 17.35 | 69.28 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 47.43 | 24.19 | 71.83 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 159.66 | 297.08 | 443.91 | 1227.15 | 22.56 |
| Interest Coverage Ratio (Post Tax) (%) | 110.85 | 202.17 | 305.58 | 854.68 | 15.97 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 11954.71 | 13157.64 | 9197.77 | 4488.68 | 5111.73 |
| EV / Net Operating Revenue (X) | 4.68 | 5.51 | 4.03 | 2.08 | 2.41 |
| EV / EBITDA (X) | 13.94 | 18.35 | 13.40 | 6.69 | 8.10 |
| MarketCap / Net Operating Revenue (X) | 4.69 | 5.54 | 4.16 | 2.22 | 2.65 |
| Retention Ratios (%) | 0.00 | 0.00 | 41.45 | 17.34 | 69.27 |
| Price / BV (X) | 3.59 | 4.70 | 4.07 | 2.24 | 2.74 |
| Price / Net Operating Revenue (X) | 4.69 | 5.54 | 4.16 | 2.22 | 2.65 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.09 | 0.07 |
